SCHEMBL8911970

SCHEMBL8911970

COC(=O)CN(C)c1ccc(C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 2/20 0.46
GLA P06280 1/20 0.46
KMT2A Q03164 1/20 0.46
RAB9A P51151 4/20 0.45
PKM P14618 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
HTT P42858 2/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
PTPN1 P18031 1/20 0.40
POLB P06746 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32670823 0.85 CA12 (0.42) ALDH1A1KDM4ERAB9AHSD17B10MAPT
SCHEMBL5004063 0.84 ALDH1A1 (0.46) ALDH1A1RAB9APKMHSD17B10TDP1
Methyl Alcohol SCHEMBL28809124 0.84 CA12 (0.41) ALDH1A1KDM4ERAB9AHSD17B10MAPT
SCHEMBL28703573 0.84 RAB9A (0.45) ALDH1A1KDM4EKMT2ARAB9AHSD17B10
SCHEMBL28690878 0.84 MAPT (0.50) ALDH1A1KMT2ARAB9AHSD17B10HTT
SCHEMBL28791227 0.84 HPGD (0.46) ALDH1A1KDM4EGLAKMT2ARAB9A
SCHEMBL5345206 0.83 POLB (0.44) ALDH1A1KDM4EGLAKMT2AHTT
SCHEMBL28791233 0.82 HPGD (0.45) ALDH1A1KDM4EGLAKMT2ARAB9A
SCHEMBL8935197 0.82 KMT2A (0.48) ALDH1A1KDM4EGLAKMT2ARAB9A
SCHEMBL10175567 0.82 ALDH1A1 (0.42) ALDH1A1KDM4EKMT2ARAB9AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117736104-A Method for synthesizing butanedicarboxylate derivative by visible light catalysis 常州大学 2024-03-22 CN disclosed
CN-109456249-B Synthetic method of isatin derivative 西北师范大学 2022-03-08 CN disclosed
US-20120238750-A1 AROMATIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2012-09-20 US disclosed
US-8236826-B2 Diarylether derivatives as antitumor agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-08-07 US disclosed
US-8188277-B2 Aromatic compounds for suppressing the generation of collagen OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-05-29 US disclosed
US-20100004438-A1 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-01-07 US disclosed
US-20070270422-A1 Aromatic Compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238750-A1 AROMATIC COMPOUND CBR1, CBR3, CYP1A1 ALDH1A1 565/4885KDM4E 1219/4885GLA 3428/4885
US-20100004438-A1 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS ROS1, CBR1, CBR3 ALDH1A1 265/4885KDM4E 2010/4885GLA 2816/4885
US-20070270422-A1 Aromatic Compounds COL1A1, COL2A1, COL14A1 ALDH1A1 475/4885KDM4E 988/4885GLA 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.